Leaving the study early ‐ medium term ‐ any reason · patients with schizophrenia
It is very uncertain whether haloperidol changes leaving the study early due to any reason as a measure of overall… compared with first‐generation antipsychotics (very low certainty).
1 finding from 1 review
Material deficiency (retention/adaptation loss; re-treatment) · Dentate children and adults with non-cavitated proximal caries lesions extending into enamel or dentine (not pulp) in primary or permanent…
1 finding from 1 review
Acceptability · Patients of any age undergoing orthodontic treatment with fixed appliances and requiring anchorage (adolescents to adults up to 48-54 years)
1 finding from 1 review
Reported narratively in 1 study (Feldmann 2007): limitations in daily life and jaw function were low to moderate throughout the trial with no differences between anchorage groups; impact on mood and appearance peaked…
1 study · 113 participants
GRADE not reported
Leaving the study early · patients with schizophrenia
It is very uncertain whether adjunctive carbamazepine + antipsychotics changes acceptability of treatment Leaving the study early due to any reason compared with placebo/no adjunctive treatment + antipsychotics (very low certainty).
1 finding from 1 review
Leaving the study early · patients with schizophrenia
It is very uncertain whether perazine changes acceptability of treatment Leaving the study early due to any reason compared with placebo (very low certainty).
1 finding from 1 review
Acceptability of treatment ‐ leaving the study early · patients with schizophrenia
Perazine showed no clear difference in acceptability of treatment Leaving the studies early due to any reason compared with other antipsychotics (low certainty).
1 finding from 1 review
Unacceptable malunion · Children and adolescents with femoral shaft fractures
Surgical interventions probably leads to lower unacceptable malunion Assessed by imaging compared with conservative interventions (moderate certainty).
1 finding from 1 review
Acceptability ‐ total dropouts · participants with panic disorder
It is very uncertain whether rTMS + pharmacotherapy changes acceptability: dropouts for any reason number of dropouts compared with sham rTMS + pharmacotherapy (very low certainty).
1 finding from 1 review
Acceptability ‐ dropouts due to adverse effects · participants with panic disorder
It is very uncertain whether rTMS + pharmacotherapy changes acceptability: dropouts for adverse effects number of dropouts compared with sham rTMS + pharmacotherapy (very low certainty).
1 finding from 1 review
Improvment of social function: Self‐reported social adaptation scale (SASS) (low=poor), acute effect SASS. Scale from: 0 to 60. · participants with panic disorder
1 finding from 1 review
Acceptability of treatment ‐ leaving the study early · patients with schizophrenia
1 finding from 1 review
Acceptability of treatment ‐ leaving the study early · patients with schizophrenia
FLUPHENAZINE showed no clear difference in acceptability of treatment‐leaving the study early due to any reason compared with LOW‐POTENCY ANTIPSYCHOTIC DRUGS (moderate certainty).
1 finding from 1 review
Acceptability of treatment ‐ leaving the study early · patients with schizophrenia
It is very uncertain whether comparison 1: PERPHENAZINE changes acceptability of treatment ‐ leaving the study early due to any reason compared with LOW‐POTENCY ANTIPSYCHOTIC DRUGS (very low certainty).
1 finding from 1 review
Acceptability of treatment ‐ leaving the study early · patients with schizophrenia
Trifluoperazine showed no clear difference in leaving the study early: 1. Acceptability of treatment ‐ leaving… compared with low‐potency antipsychotic drugs (low certainty).
1 finding from 1 review
Family outcome ‐ understanding schizophrenia, average endpoint score Patient Rejection Scale (PRS ‐ high score = greater acceptance). Scale from: 24 to 168. · patients with schizophrenia
1 finding from 1 review
Acceptability (of intervention): Leaving the studies early – any reason Loss to · patients with treatment compliance for people with serious mental illness
1 finding from 1 review
Acceptability (of intervention): Leaving the studies early – any reason Loss to · patients with treatment compliance for people with serious mental illness
INFORMATION AND COMMUNICATION TECHNOLOGY (ICT) FOR PROMPTING/SUPPORT… showed no clear difference in acceptability (of intervention): Leaving the studies early – any… compared with STANDARD CARE (low certainty).
1 finding from 1 review
Global assessment of treatment success · acute gout
Canakinumab probably leads to higher participant global assessment of response to treatment: good or… compared with triamcinolone acetonide (moderate certainty).
1 finding from 1 review
Acceptability · somatoform disorders in adults
Natural products showed no clear difference in acceptability (all‐cause drop‐outs4) compared with placebo (low certainty).
1 finding from 1 review
Acceptability · somatoform disorders in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found